See What the Human Eye Cannot Detect

Creatinine rising 0.1 mg/dL per year — no single test triggers an alarm, but the trajectory points to kidney disease in 3 years.

Fasting glucose drifting from 95 to 110 mg/dL over 18 months. Each test is still normal, but the direction is not.

PSA doubling velocity over 12 months — a signal that warrants investigation even when each individual value falls within the reference range.

ALT creeping upward after starting a new medication. A single test might look fine, but the trend reveals emerging liver stress.

Hemoglobin dropping by 0.5 g/dL per year — so slowly that each individual test stays in range, but the patient is heading toward transfusion territory.

TSH climbing from 2.5 to 4.8 over two years. Still within reference ranges, but the trajectory suggests emerging thyroid dysfunction.

LDL rising from 110 to 145 mg/dL over 3 years. Each value falls below the intervention threshold, but the slope signals growing cardiovascular risk requiring primary prevention.

WBC count dropping from 6,200 to 4,100 over 18 months. Every result is normal, but the trend may reveal myelodysplasia or drug effect before symptoms appear.

Platelets declining from 220,000 to 155,000 over 2 years. No single value triggers an alarm, but the sustained drop points to progressive liver fibrosis requiring FibroScan.